Nurix Therapeutics, Inc. (NRIX)
14.92
-0.13
(-0.86%)
USD |
NASDAQ |
Mar 19, 16:00
14.89
-0.03
(-0.20%)
After-Hours: 06:59
Nurix Therapeutics Shareholders Equity (Quarterly) : 538.75M for Nov. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.220B |
| Scholar Rock Holding Corp. | 245.49M |
| Stoke Therapeutics, Inc. | 352.46M |
| Immunome, Inc. | 634.34M |
| Gilead Sciences, Inc. | 22.70B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 702.56M |
| Total Liabilities (Quarterly) | 163.82M |
| Debt to Equity Ratio | 0.1034 |
| Current Ratio | 7.018 |
| Net Debt Paydown Yield | -0.32% |